HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leu518Pro mutation of the beta ig-h3 gene causes lattice corneal dystrophy type I.

AbstractPURPOSE:
To describe a Japanese family with lattice corneal dystrophy type I, which segregates with a novel mutation, Leu518Pro of the beta ig-h3 gene.
METHODS:
DNA was extracted from leukocytes in four members (three affected and one unaffected) of a Japanese family with lattice corneal dystrophy type I. Exon 12 of the beta ig-h3 gene was amplified and analyzed with a molecular biologic method. Clinical data were also collected.
RESULTS:
Three generations of this family have been positively diagnosed with lattice corneal dystrophy, indicating autosomal dominant inheritance. We found a heterozygous point mutation that segregates with the disease phenotype. It was a single base-pair transition (CTG to CCG, Leu to Pro).
CONCLUSION:
Although it is extremely rare compared with the Arg124Cys mutation of the beta ig-h3 gene, Leu518Pro mutation of the beta ig-h3 also causes lattice corneal dystrophy type I.
AuthorsS Endo, T H Nguyen, K Fujiki, Y Hotta, K Nakayasu, T Yamaguchi, N Ishida, A Kanai
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 128 Issue 1 Pg. 104-6 (Jul 1999) ISSN: 0002-9394 [Print] United States
PMID10482106 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Extracellular Matrix Proteins
  • Neoplasm Proteins
  • Transforming Growth Factor beta
  • betaIG-H3 protein
  • DNA
  • Proline
  • Leucine
Topics
  • Adolescent
  • Adult
  • Base Sequence
  • Cornea (pathology)
  • Corneal Dystrophies, Hereditary (genetics, pathology, surgery)
  • DNA (analysis)
  • Exons (genetics)
  • Extracellular Matrix Proteins
  • Female
  • Humans
  • Keratoplasty, Penetrating
  • Leucine (genetics)
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Neoplasm Proteins (genetics)
  • Pedigree
  • Point Mutation
  • Proline (genetics)
  • Transforming Growth Factor beta (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: